Accurate, de-identified patient data: The key to a longitudinal patient journey

A data-rich longitudinal patient journey is key to research and development, commercialization and marketing in the world of life sciences and pharmaceuticals. But how does a comprehensive patient journey come to fruition? At its core is high-quality...

How RWE can support drug development during COVID-19 and beyond: Q&A with Dr. Diana Brainard of Gilead Sciences

The COVID-19 pandemic introduced novel challenges for global biopharma organizations, as many adapted their clinical trial operations while working to develop lifesaving interventions. At Gilead Sciences, this need to quickly pivot led to an increase...

How RWE can support drug development during COVID-19 and beyond: Q&A with Dr. Diana Brainard of Gile...

The COVID-19 pandemic introduced novel challenges for global biopharma organizations, as many adapted their clinical tri...

The role of RWE: Longitudinal patient insights bridging clinical and real-world data

COVID-19 has heightened the need for an expanded understanding of clinical trial populations and patient insights both d...

The modern way to data: Design, build and implement your data strategy

Building a modern data infrastructure within today’s healthcare enterprise is challenging on many levels. Your organizat...

Subscribe to the HealthVerity blog